SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-000319
Filing Date
2024-01-03
Accepted
2024-01-03 18:32:51
Documents
3
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704324760.html 4  
1 FORM 4 wk-form4_1704324760.xml 4 3188
2 EX-24 powerofattorney_davisx65.htm EX-24 3789
3 powerofattorney_davisx65001.jpg GRAPHIC 203143
  Complete submission text file 0001628280-24-000319.txt   288300
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9393 TOWNE CENTRE DRIVE STE 200 SAN DIEGO CA 92121
Business Address
Martinez Maria E (Reporting) CIK: 0001761768 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 24508874